LISDEXAMFETAMINE DIMESYLATE

LISDEXAMFETAMINE DIMESYLATE was reported 33463 times

LISDEXAMFETAMINE DIMESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHESUS INCOMPATIBILITY 68 0.5620
1 AMPHETAMINES NEGATIVE 28 0.5283
2 CHANGE IN SUSTAINED ATTENTION 43 0.1429
3 ADULTERATED PRODUCT 28 0.1400
4 STEROID DEPENDENCE 111 0.1264
5 CATARRH 111 0.1228
6 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.1176
7 NEGATIVISM 86 0.1133
8 DERMATILLOMANIA 64 0.1074
9 ONYCHOPHAGIA 29 0.1051
10 INABILITY TO AFFORD MEDICATION 1036 0.1042
11 JAW CLICKING 19 0.0892
12 AMPHETAMINES POSITIVE 66 0.0881
13 CONDUCT DISORDER 17 0.0825
14 TRICHOTILLOMANIA 46 0.0785
15 PREMENSTRUAL DYSPHORIC DISORDER 15 0.0739
16 BINGE EATING 75 0.0695
17 PRODUCT AVAILABILITY ISSUE 1583 0.0695
18 BURNS SECOND DEGREE 120 0.0683
19 EDUCATIONAL PROBLEM 112 0.0673
20 TIC 362 0.0663
21 URINE AMPHETAMINE POSITIVE 21 0.0640
22 DRUG EFFECT VARIABLE 72 0.0635
23 DRUG EFFECT INCREASED 181 0.0572
24 INTENTIONAL SELF-INJURY 1109 0.0549
25 EXECUTIVE DYSFUNCTION 28 0.0517
26 CRYPTOSPORIDIOSIS INFECTION 26 0.0495
27 DISTURBANCE IN SOCIAL BEHAVIOUR 116 0.0492
28 INSURANCE ISSUE 738 0.0482
29 SUSPECTED PRODUCT TAMPERING 27 0.0481
30 IMPULSIVE BEHAVIOUR 175 0.0466
31 OPPOSITIONAL DEFIANT DISORDER 18 0.0456
32 DEFIANT BEHAVIOUR 14 0.0455
33 PRODUCT TAMPERING 79 0.0440
34 COMPULSIVE HOARDING 14 0.0436
35 PENIS INJURY 15 0.0417
36 ATTENTION DEFICIT HYPERACTIVITY DISORDER 175 0.0415
37 ABDOMINAL LYMPHADENOPATHY 36 0.0415
38 SOCIAL ANXIETY DISORDER 27 0.0411
39 ALCOHOL POISONING 110 0.0410
40 THEFT 27 0.0406
41 LOGORRHOEA 142 0.0403
42 THERAPEUTIC PRODUCT EFFECT VARIABLE 155 0.0399
43 HYPERMETABOLISM 21 0.0396
44 JOB DISSATISFACTION 25 0.0385
45 BREECH PRESENTATION 47 0.0373
46 PRODUCT PHYSICAL ISSUE 706 0.0350
47 HYPOPNOEA 118 0.0340
48 SLEEP-RELATED EATING DISORDER 31 0.0331
49 COMPULSIONS 22 0.0330
50 DISTRACTIBILITY 36 0.0312
51 CATAPLEXY 39 0.0275
52 PRODUCT ADMINISTRATION INTERRUPTED 210 0.0267
53 PRE-EXISTING CONDITION IMPROVED 164 0.0262
54 SOMATIC SYMPTOM DISORDER 28 0.0259
55 FLAT AFFECT 59 0.0255
56 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 33 0.0244
57 AUTISM SPECTRUM DISORDER 134 0.0243
58 DISTURBANCE IN ATTENTION 1284 0.0238
59 SUBSTANCE USE 37 0.0237
60 HEPATITIS VIRAL 19 0.0237
61 NARCOLEPSY 43 0.0228
62 PSYCHOTIC BEHAVIOUR 23 0.0226
63 THERAPEUTIC RESPONSE CHANGED 142 0.0224
64 BRUXISM 117 0.0217
65 JAUNDICE NEONATAL 40 0.0211
66 CLAUSTROPHOBIA 23 0.0211
67 ANTISOCIAL BEHAVIOUR 21 0.0210
68 DISSOCIATION 161 0.0210
69 DRUG DIVERSION 128 0.0207
70 SELF-DESTRUCTIVE BEHAVIOUR 18 0.0206
71 DRUG SCREEN NEGATIVE 36 0.0204
72 TACHYPHRENIA 67 0.0193
73 SLEEP PARALYSIS 28 0.0191
74 FOETAL DISTRESS SYNDROME 40 0.0188
75 EMOTIONAL POVERTY 33 0.0188
76 PSYCHOMOTOR HYPERACTIVITY 307 0.0185
77 INTENTIONAL OVERDOSE 1155 0.0180
78 INAPPROPRIATE AFFECT 28 0.0177
79 PAROSMIA 129 0.0171
80 DRUG TOLERANCE 85 0.0168
81 BRONCHIECTASIS 113 0.0168
82 PRESCRIBED OVERDOSE 319 0.0165
83 MAST CELL ACTIVATION SYNDROME 23 0.0164
84 LOSS OF EMPLOYMENT 49 0.0162
85 ORAL ADMINISTRATION COMPLICATION 15 0.0161
86 SOCIAL AVOIDANT BEHAVIOUR 90 0.0155
87 BLOOD HIV RNA INCREASED 28 0.0154
88 PERFORMANCE STATUS DECREASED 72 0.0154
89 RHINITIS 123 0.0152
90 AFFECT LABILITY 146 0.0152
91 GINGIVAL PAIN 120 0.0151
92 ANGER 505 0.0149
93 IMPATIENCE 28 0.0149
94 CARDIAC MURMUR 127 0.0147
95 ENURESIS 59 0.0146
96 HOSTILITY 37 0.0145
97 INTRUSIVE THOUGHTS 17 0.0144
98 OBSESSIVE THOUGHTS 26 0.0144
99 GROWTH RETARDATION 42 0.0143
100 DRUG EFFECT DECREASED 766 0.0142
101 FRUSTRATION TOLERANCE DECREASED 113 0.0140
102 BIPOLAR DISORDER 152 0.0140
103 IMPAIRED QUALITY OF LIFE 198 0.0138
104 PULSE ABNORMAL 33 0.0137
105 INITIAL INSOMNIA 140 0.0136
106 TERMINAL INSOMNIA 24 0.0135
107 OBSESSIVE-COMPULSIVE DISORDER 108 0.0134
108 STRESS AT WORK 15 0.0133
109 IRRITABILITY 795 0.0132
110 IMPULSE-CONTROL DISORDER 27 0.0131
111 SOMNAMBULISM 86 0.0131
112 DISORGANISED SPEECH 24 0.0130
113 AGGRESSION 650 0.0130
114 VIOLENCE-RELATED SYMPTOM 20 0.0129
115 FEELING JITTERY 245 0.0128
116 PARANOIA 220 0.0127
117 HANGOVER 44 0.0125
118 DRUG EFFECT LESS THAN EXPECTED 184 0.0124
119 APATHY 181 0.0124
120 SEIZURE LIKE PHENOMENA 21 0.0124
121 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18 0.0123
122 LIBIDO INCREASED 25 0.0123
123 BIPOLAR I DISORDER 27 0.0123
124 SUICIDAL BEHAVIOUR 51 0.0122
125 SELF-INJURIOUS IDEATION 51 0.0121
126 BRAIN FOG 189 0.0120
127 HYPERSEXUALITY 22 0.0120
128 FEELING OF DESPAIR 55 0.0118
129 ABNORMAL BEHAVIOUR 456 0.0115
130 ABNORMAL SLEEP-RELATED EVENT 15 0.0114
131 IMPAIRED WORK ABILITY 242 0.0113
132 HYPERPHAGIA 45 0.0113
133 TINEA PEDIS 18 0.0113
134 PERSONALITY CHANGE 104 0.0112
135 MANIA 184 0.0112
136 HUNGER 155 0.0111
137 EUPHORIC MOOD 113 0.0110
138 HYPERACUSIS 41 0.0110
139 THERAPEUTIC RESPONSE SHORTENED 365 0.0110
140 POST-TRAUMATIC STRESS DISORDER 73 0.0109
141 GENERALISED ANXIETY DISORDER 16 0.0109
142 AFFECTIVE DISORDER 85 0.0108
143 UNDERWEIGHT 21 0.0106
144 CRYING 384 0.0106
145 SUSPECTED PRODUCT QUALITY ISSUE 19 0.0104
146 ENERGY INCREASED 60 0.0102
147 EXCESSIVE EYE BLINKING 15 0.0101
148 DRUG TITRATION ERROR 26 0.0101
149 SLEEP DEFICIT 21 0.0099
150 SUICIDAL IDEATION 900 0.0098
151 SNORING 37 0.0098
152 DAYDREAMING 15 0.0097
153 NASAL SEPTUM DEVIATION 19 0.0097
154 APPETITE DISORDER 64 0.0096
155 DEPRESSIVE SYMPTOM 34 0.0096
156 NEGATIVE THOUGHTS 28 0.0095
157 SELF INJURIOUS BEHAVIOUR 29 0.0095
158 HOMICIDAL IDEATION 38 0.0094
159 PRODUCT SUBSTITUTION ISSUE 535 0.0093
160 EXPOSURE VIA BREAST MILK 37 0.0093
161 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 445 0.0093
162 HYPOMANIA 34 0.0092
163 ABNORMAL LOSS OF WEIGHT 62 0.0091
164 FOOD INTERACTION 16 0.0091
165 BEHAVIOUR DISORDER 49 0.0090
166 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 15 0.0090
167 MOOD ALTERED 244 0.0089
168 SOCIAL PROBLEM 37 0.0089
169 PRODUCT QUALITY ISSUE 1205 0.0089
170 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63 0.0088
171 EMOTIONAL DISORDER 270 0.0087
172 SLEEP APNOEA SYNDROME 167 0.0087
173 PHYSICAL ASSAULT 18 0.0086
174 DRUG EFFECT DELAYED 39 0.0086
175 PSYCHOTIC DISORDER 254 0.0086
176 GAMBLING DISORDER 23 0.0085
177 SEDATION 222 0.0085
178 DEPRESSED MOOD 447 0.0084
179 HYPERREFLEXIA 29 0.0083
180 MOOD SWINGS 265 0.0083
181 COMPULSIVE SHOPPING 17 0.0083
182 YAWNING 22 0.0082
183 DRUG SCREEN POSITIVE 65 0.0082
184 PREMATURE DELIVERY 130 0.0082
185 CLUMSINESS 22 0.0081
186 THINKING ABNORMAL 148 0.0079
187 CRANIOCEREBRAL INJURY 24 0.0079
188 PRODUCT FORMULATION ISSUE 52 0.0079
189 ELECTRIC SHOCK SENSATION 22 0.0079
190 HALLUCINATIONS, MIXED 33 0.0078
191 MYDRIASIS 100 0.0078
192 PATIENT DISSATISFACTION WITH TREATMENT 15 0.0078
193 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 553 0.0078
194 ANOREXIA 100 0.0078
195 DYSPHEMIA 34 0.0077
196 INCREASED APPETITE 147 0.0077
197 PANIC REACTION 55 0.0076
198 HALLUCINATION, AUDITORY 120 0.0075
199 THERAPEUTIC REACTION TIME DECREASED 22 0.0075
200 STARING 18 0.0074
201 TEARFULNESS 32 0.0074
202 SCREAMING 47 0.0074
203 TRISMUS 38 0.0074
204 VIRAL MUTATION IDENTIFIED 27 0.0073
205 THERAPEUTIC RESPONSE UNEXPECTED 326 0.0073
206 CONCUSSION 56 0.0072
207 AGITATION 525 0.0071
208 TEMPOROMANDIBULAR JOINT SYNDROME 19 0.0071
209 PRODUCT USE ISSUE 1335 0.0071
210 FOOD CRAVING 37 0.0070
211 WITHDRAWAL SYNDROME 295 0.0070
212 MENOPAUSE 18 0.0070
213 DEREALISATION 15 0.0070
214 PANIC ATTACK 254 0.0070
215 SYNOVIAL CYST 32 0.0069
216 SINUS PAIN 16 0.0069
217 SWOLLEN TONGUE 214 0.0068
218 MAJOR DEPRESSION 50 0.0068
219 NEUROLOGICAL SYMPTOM 39 0.0068
220 FEELING DRUNK 50 0.0067
221 NEAR DEATH EXPERIENCE 22 0.0067
222 FREQUENT BOWEL MOVEMENTS 180 0.0067
223 NO ADVERSE EVENT 1206 0.0066
224 ACNE CYSTIC 20 0.0066
225 TUBULOINTERSTITIAL NEPHRITIS 124 0.0066
226 RESTLESS LEGS SYNDROME 120 0.0066
227 ANXIETY 1851 0.0065
228 PERSONALITY DISORDER 17 0.0065
229 NIGHTMARE 224 0.0065
230 POOR QUALITY PRODUCT ADMINISTERED 68 0.0064
231 ALCOHOL ABUSE 17 0.0064
232 PERIPHERAL COLDNESS 87 0.0063
233 HEPATIC PAIN 27 0.0063
234 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 39 0.0063
235 ANORGASMIA 17 0.0063
236 DEPRESSION 1415 0.0062
237 SELF ESTEEM DECREASED 15 0.0062
238 DRUG PRESCRIBING ERROR 119 0.0062
239 FRUSTRATION 22 0.0061
240 ENDOMETRIOSIS 29 0.0061
241 PARANASAL SINUS DISCOMFORT 23 0.0061
242 MUSCLE TWITCHING 140 0.0061
243 SEXUAL DYSFUNCTION 71 0.0060
244 LYME DISEASE 20 0.0060
245 ANXIETY DISORDER 20 0.0060
246 SUSPECTED COUNTERFEIT PRODUCT 23 0.0058
247 THERAPY CHANGE 57 0.0058
248 FEELING ABNORMAL 1368 0.0057
249 ALCOHOL USE 21 0.0057
250 INSOMNIA 1505 0.0056
251 MIGRAINE 538 0.0056
252 COELIAC DISEASE 55 0.0056
253 DECREASED INTEREST 33 0.0056
254 THERAPEUTIC PRODUCT EFFECT DECREASED 249 0.0056
255 PALPITATIONS 649 0.0055
256 PRODUCT TASTE ABNORMAL 75 0.0055
257 SOMNOLENCE 1104 0.0055
258 PRODUCT SUPPLY ISSUE 39 0.0055
259 DRUG SCREEN FALSE POSITIVE 15 0.0054
260 UNEVALUABLE EVENT 407 0.0054
261 MENTAL DISORDER 234 0.0054
262 ALCOHOLISM 23 0.0054
263 HORMONE LEVEL ABNORMAL 26 0.0053
264 PSYCHIATRIC SYMPTOM 39 0.0053
265 SUBSTANCE ABUSE 43 0.0053
266 MUSCLE TIGHTNESS 85 0.0052
267 HEART RATE INCREASED 519 0.0052
268 SLEEP TERROR 22 0.0052
269 SLUGGISHNESS 53 0.0052
270 FOOD ALLERGY 40 0.0052
271 MALABSORPTION 27 0.0052
272 ACCIDENTAL OVERDOSE 189 0.0052
273 APHTHOUS ULCER 40 0.0052
274 POOR QUALITY SLEEP 111 0.0052
275 DRY MOUTH 417 0.0051
276 INFUSION SITE PRURITUS 16 0.0051
277 THERAPEUTIC PRODUCT EFFECT DELAYED 23 0.0050
278 ANAL FISSURE 27 0.0050
279 FORMICATION 35 0.0050
280 HYPERSOMNIA 144 0.0050
281 PRODUCT LABEL ISSUE 34 0.0050
282 BRAIN INJURY 50 0.0050
283 SLEEP DISORDER 350 0.0050
284 TONGUE DISCOMFORT 21 0.0049
285 FEAR 133 0.0049
286 HALLUCINATION, VISUAL 104 0.0049
287 RESTLESSNESS 179 0.0049
288 PRODUCT COLOUR ISSUE 25 0.0049
289 SKIN ABRASION 23 0.0049
290 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
291 SEROTONIN SYNDROME 92 0.0048
292 MIDDLE INSOMNIA 89 0.0048
293 EATING DISORDER 101 0.0047
294 AKATHISIA 64 0.0047
295 INTENTIONAL DOSE OMISSION 132 0.0046
296 PHARYNGEAL SWELLING 45 0.0046
297 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 825 0.0046
298 INTENTIONAL PRODUCT USE ISSUE 396 0.0045
299 NERVOUSNESS 236 0.0045
300 DISABILITY 89 0.0045
301 COLITIS ULCERATIVE 201 0.0045
302 HEART RATE ABNORMAL 25 0.0045
303 POOR PERIPHERAL CIRCULATION 19 0.0045
304 HEAVY MENSTRUAL BLEEDING 40 0.0044
305 VITAMIN B12 DEFICIENCY 18 0.0044
306 VITAMIN D DECREASED 38 0.0044
307 TONGUE ULCERATION 15 0.0044
308 IMPAIRED GASTRIC EMPTYING 60 0.0044
309 DELUSION 68 0.0044
310 TINNITUS 201 0.0044
311 PRODUCT PHYSICAL CONSISTENCY ISSUE 24 0.0043
312 ANAL INCONTINENCE 39 0.0043
313 OVERWEIGHT 23 0.0043
314 PHARYNGITIS STREPTOCOCCAL 46 0.0042
315 DROOLING 29 0.0042
316 DECREASED APPETITE 963 0.0041
317 TONGUE DISORDER 30 0.0041
318 DEFAECATION URGENCY 29 0.0041
319 PANIC DISORDER 16 0.0041
320 ECZEMA 215 0.0041
321 TENSION 25 0.0041
322 SKIN ODOUR ABNORMAL 16 0.0041
323 DYSKINESIA 165 0.0041
324 POLYDIPSIA 16 0.0040
325 JAW DISORDER 22 0.0040
326 NONSPECIFIC REACTION 22 0.0040
327 HAEMATOCHEZIA 221 0.0040
328 HALLUCINATION 299 0.0040
329 PRODUCT SOLUBILITY ABNORMAL 20 0.0040
330 MENTAL IMPAIRMENT 96 0.0040
331 FEELING OF BODY TEMPERATURE CHANGE 23 0.0039
332 FOOD POISONING 21 0.0039
333 SUICIDE ATTEMPT 237 0.0039
334 WEIGHT FLUCTUATION 40 0.0038
335 HEPATIC ENZYME ABNORMAL 19 0.0038
336 AUTOIMMUNE DISORDER 37 0.0038
337 HYPERHIDROSIS 489 0.0038
338 HYPERVENTILATION 22 0.0038
339 METABOLIC DISORDER 22 0.0038
340 CAESAREAN SECTION 44 0.0038
341 SYSTEMIC LUPUS ERYTHEMATOSUS 133 0.0037
342 SEASONAL ALLERGY 53 0.0037
343 TRANSFUSION 39 0.0037
344 DYSGEUSIA 276 0.0037
345 ADVERSE DRUG REACTION 333 0.0037
346 AUTOIMMUNE THYROIDITIS 14 0.0037
347 PRODUCT PRESCRIBING ERROR 88 0.0037
348 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
349 EYE MOVEMENT DISORDER 25 0.0036
350 DRUG INEFFECTIVE 4768 0.0036
351 ROAD TRAFFIC ACCIDENT 151 0.0036
352 VERTIGO 219 0.0036
353 CONDITION AGGRAVATED 1085 0.0036
354 WEIGHT DECREASED 996 0.0036
355 INCOHERENT 23 0.0035
356 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
357 RECTAL HAEMORRHAGE 152 0.0035
358 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 24 0.0035
359 PREMATURE BABY 106 0.0035
360 URINE ABNORMALITY 16 0.0035
361 TENSION HEADACHE 15 0.0035
362 INCORRECT DOSAGE ADMINISTERED 17 0.0035
363 MOUTH SWELLING 20 0.0035
364 NOCTURIA 42 0.0035
365 EAR INFECTION 92 0.0035
366 PRODUCT DISTRIBUTION ISSUE 32 0.0034
367 EAR PAIN 67 0.0034
368 TACHYCARDIA 306 0.0034
369 STRESS CARDIOMYOPATHY 20 0.0034
370 MUCOUS STOOLS 17 0.0034
371 LETHARGY 197 0.0034
372 THIRST 61 0.0034
373 PATHOGEN RESISTANCE 31 0.0034
374 BOWEL MOVEMENT IRREGULARITY 26 0.0034
375 BLOOD PROLACTIN INCREASED 16 0.0034
376 ANAL FISTULA 18 0.0034
377 SENSORY DISTURBANCE 54 0.0034
378 MEDICATION ERROR 187 0.0034
379 REBOUND EFFECT 38 0.0034
380 DYSPHORIA 17 0.0034
381 BLEPHAROSPASM 21 0.0033
382 RETCHING 71 0.0033
383 PRODUCT TEMPERATURE EXCURSION ISSUE 17 0.0033
384 THERAPY INTERRUPTED 236 0.0033
385 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 669 0.0033
386 COLD SWEAT 58 0.0033
387 QUALITY OF LIFE DECREASED 44 0.0033
388 GASTROENTERITIS VIRAL 59 0.0033
389 MENSTRUAL DISORDER 27 0.0033
390 IMPAIRED DRIVING ABILITY 37 0.0033
391 CEREBRAL DISORDER 24 0.0032
392 SENSATION OF FOREIGN BODY 27 0.0032
393 ARTHRITIS 250 0.0032
394 DRUG WITHDRAWAL SYNDROME NEONATAL 47 0.0032
395 COGNITIVE DISORDER 148 0.0032
396 HYPOPHAGIA 81 0.0032
397 VIRAL UPPER RESPIRATORY TRACT INFECTION 15 0.0032
398 SURGERY 185 0.0032
399 ERECTILE DYSFUNCTION 81 0.0032
400 SKIN LACERATION 34 0.0031
401 SKIN INFECTION 35 0.0031
402 PERIPHERAL VASCULAR DISORDER 16 0.0031
403 ACCIDENT 37 0.0031
404 ILLNESS 318 0.0031
405 HEREDITARY ANGIOEDEMA 33 0.0031
406 POISONING DELIBERATE 29 0.0031
407 THERAPEUTIC RESPONSE DECREASED 185 0.0030
408 DRUG LEVEL DECREASED 31 0.0030
409 WRONG TECHNIQUE IN DRUG USAGE PROCESS 110 0.0030
410 OBESITY 48 0.0030
411 MEMORY IMPAIRMENT 413 0.0030
412 HYSTERECTOMY 26 0.0030
413 APPENDICITIS 28 0.0030
414 WEIGHT INCREASED 665 0.0030
415 AMENORRHOEA 52 0.0030
416 NEURALGIA 72 0.0030
417 APNOEA 23 0.0030
418 HEAD DISCOMFORT 52 0.0029
419 BLOOD PRESSURE INCREASED 444 0.0029
420 DENTAL CARIES 32 0.0029
421 HEADACHE 1805 0.0029
422 SINUS DISORDER 57 0.0029
423 HYPERTENSIVE CRISIS 32 0.0029
424 STREPTOCOCCAL INFECTION 16 0.0029
425 VITAMIN D DEFICIENCY 28 0.0029
426 TREMOR 476 0.0029
427 PRODUCT ODOUR ABNORMAL 30 0.0029
428 CONFUSIONAL STATE 462 0.0029
429 ECONOMIC PROBLEM 43 0.0028
430 PHOTOPHOBIA 53 0.0028
431 ACNE 213 0.0028
432 ANKYLOSING SPONDYLITIS 37 0.0028
433 HYPOAESTHESIA 416 0.0028
434 ABDOMINAL DISCOMFORT 465 0.0028
435 OCULAR DISCOMFORT 31 0.0028
436 RESPIRATION ABNORMAL 19 0.0028
437 DERMATITIS ATOPIC 145 0.0027
438 HAIR GROWTH ABNORMAL 19 0.0027
439 PRODUCT PREPARATION ISSUE 18 0.0027
440 UTERINE LEIOMYOMA 20 0.0027
441 DEAFNESS UNILATERAL 15 0.0027
442 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
443 MICTURITION URGENCY 31 0.0027
444 INFUSION SITE SWELLING 17 0.0027
445 FATIGUE 2100 0.0027
446 DECREASED ACTIVITY 29 0.0027
447 MULTIPLE ALLERGIES 21 0.0027
448 FEELING HOT 164 0.0027
449 SYMPTOM RECURRENCE 16 0.0027
450 PRODUCT USE COMPLAINT 42 0.0027
451 IRRITABLE BOWEL SYNDROME 57 0.0027
452 MOUTH ULCERATION 56 0.0027
453 ABDOMINAL PAIN UPPER 545 0.0026
454 PROCTALGIA 17 0.0026
455 FIBROMYALGIA 64 0.0026
456 DYSTONIA 51 0.0026
457 ACTIVITIES OF DAILY LIVING IMPAIRED 52 0.0026
458 TARDIVE DYSKINESIA 74 0.0026
459 MUSCLE SPASTICITY 32 0.0026
460 MENISCUS INJURY 16 0.0026
461 NERVE COMPRESSION 24 0.0026
462 SARS-COV-2 TEST POSITIVE 34 0.0026
463 FOREIGN BODY IN REPRODUCTIVE TRACT 23 0.0026
464 DYSMENORRHOEA 34 0.0026
465 SCRATCH 27 0.0026
466 SPEECH DISORDER 134 0.0026
467 LIGAMENT SPRAIN 25 0.0025
468 INCORRECT DOSE ADMINISTERED 577 0.0025
469 SINUSITIS 258 0.0025
470 ORAL HERPES 49 0.0025
471 VISION BLURRED 344 0.0025
472 COVID-19 439 0.0025
473 ANGIOPATHY 14 0.0025
474 GALACTORRHOEA 16 0.0025
475 VISUAL FIELD DEFECT 18 0.0025
476 TYPE 1 DIABETES MELLITUS 15 0.0025
477 LYMPHOCYTE COUNT DECREASED 44 0.0025
478 BLOOD TESTOSTERONE DECREASED 17 0.0025
479 INFUSION SITE PAIN 32 0.0025
480 PRODUCT DOSE OMISSION ISSUE 730 0.0025
481 HEART RATE IRREGULAR 56 0.0025
482 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
483 PALLOR 67 0.0025
484 MATERNAL EXPOSURE DURING PREGNANCY 219 0.0025
485 ADVERSE EVENT 226 0.0024
486 NEUTROPHIL COUNT INCREASED 25 0.0024
487 DEVICE INFORMATION OUTPUT ISSUE 19 0.0024
488 COORDINATION ABNORMAL 34 0.0024
489 CARPAL TUNNEL SYNDROME 34 0.0024
490 UPPER-AIRWAY COUGH SYNDROME 20 0.0024
491 LIP DRY 22 0.0024
492 PHARYNGITIS 30 0.0024
493 BLADDER DISORDER 24 0.0024
494 BLOOD PRESSURE ABNORMAL 48 0.0024
495 DRUG DOSE OMISSION 398 0.0024
496 MENSTRUATION DELAYED 26 0.0024
497 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
498 DISCOMFORT 145 0.0024
499 OFF LABEL USE 2063 0.0024
500 PRESYNCOPE 57 0.0023
501 PRODUCT PRESCRIBING ISSUE 51 0.0023
502 PARAESTHESIA 368 0.0023
503 EAR DISCOMFORT 24 0.0023
504 APHASIA 70 0.0023
505 HYPERAESTHESIA 19 0.0023
506 VENTRICULAR EXTRASYSTOLES 24 0.0023
507 OROPHARYNGEAL PAIN 213 0.0023
508 ARTHROPOD BITE 17 0.0023
509 NECK PAIN 128 0.0023
510 INTERVERTEBRAL DISC PROTRUSION 50 0.0023
511 BEDRIDDEN 30 0.0023
512 DERMATITIS CONTACT 26 0.0023
513 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
514 RESPIRATORY RATE INCREASED 20 0.0023
515 PREGNANCY 45 0.0022
516 SEIZURE 259 0.0022
517 ORAL DISCOMFORT 31 0.0022
518 NEPHROLITHIASIS 102 0.0022
519 POOR VENOUS ACCESS 23 0.0022
520 HAEMORRHOIDS 43 0.0022
521 OVARIAN CYST 22 0.0022
522 GYNAECOMASTIA 68 0.0022
523 VIRAL INFECTION 73 0.0022
524 PAIN IN JAW 62 0.0022
525 GENERALISED TONIC-CLONIC SEIZURE 36 0.0022
526 DEEP VEIN THROMBOSIS 141 0.0022
527 FOOT FRACTURE 41 0.0022
528 EOSINOPHIL COUNT INCREASED 18 0.0022
529 DRUG DISPENSING ERROR 33 0.0022
530 NERVE INJURY 24 0.0022
531 BODY TEMPERATURE INCREASED 44 0.0022
532 AMNESIA 140 0.0021
533 MALNUTRITION 24 0.0021
534 DISORIENTATION 85 0.0021
535 LOSS OF CONSCIOUSNESS 274 0.0021
536 SKIN DISCOLOURATION 98 0.0021
537 ANKLE FRACTURE 33 0.0021
538 ANHEDONIA 56 0.0021
539 DIZZINESS 1055 0.0021
540 EXPOSURE DURING PREGNANCY 131 0.0021
541 CARDIAC FAILURE ACUTE 14 0.0021
542 DERMATITIS 44 0.0021
543 URINARY INCONTINENCE 62 0.0021
544 TOOTH FRACTURE 23 0.0021
545 BREAST MASS 14 0.0021
546 DRUG INTOLERANCE 201 0.0021
547 NIGHT SWEATS 67 0.0021
548 CHEST DISCOMFORT 212 0.0021
549 GASTROINTESTINAL DISORDER 185 0.0021
550 ABNORMAL DREAMS 57 0.0021
551 LYMPHADENOPATHY 73 0.0021
552 SCHIZOPHRENIA 25 0.0021
553 NICOTINE DEPENDENCE 16 0.0021
554 HYPOAESTHESIA ORAL 31 0.0021
555 INTENTIONAL UNDERDOSE 15 0.0021
556 FEELING COLD 57 0.0020
557 COMPLICATION OF DEVICE REMOVAL 37 0.0020
558 SINUS TACHYCARDIA 29 0.0020
559 DEVICE MECHANICAL ISSUE 28 0.0020
560 TEMPERATURE INTOLERANCE 21 0.0020
561 TREATMENT FAILURE 168 0.0020
562 FEEDING DISORDER 41 0.0020
563 PRODUCT DISPENSING ERROR 44 0.0020
564 EMBEDDED DEVICE 20 0.0020
565 NAUSEA 1597 0.0020
566 INFUSION SITE ERYTHEMA 17 0.0020
567 MENSTRUATION IRREGULAR 54 0.0020
568 LIMB DISCOMFORT 62 0.0020
569 RESPIRATORY TRACT INFECTION 52 0.0020
570 FACIAL PARALYSIS 17 0.0020
571 MOVEMENT DISORDER 64 0.0020
572 TREATMENT NONCOMPLIANCE 109 0.0020
573 BREAST TENDERNESS 15 0.0020
574 INTENTIONAL PRODUCT MISUSE 174 0.0020
575 GASTROENTERITIS 29 0.0020
576 MUSCLE SPASMS 364 0.0020
577 HYPOTHYROIDISM 63 0.0020
578 BACK DISORDER 32 0.0020
579 MUSCLE STRAIN 17 0.0020
580 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
581 THERAPY CESSATION 100 0.0019
582 URINARY RETENTION 65 0.0019
583 SKIN FISSURES 38 0.0019
584 CHEST PAIN 360 0.0019
585 BLOOD IRON DECREASED 23 0.0019
586 DRUG ABUSE 161 0.0019
587 HYPERTHYROIDISM 28 0.0019
588 DRUG INTERACTION 306 0.0019
589 SYNCOPE 192 0.0019
590 PLATELET COUNT INCREASED 25 0.0019
591 SKIN REACTION 27 0.0019
592 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
593 POISONING 24 0.0019
594 GASTROINTESTINAL PAIN 21 0.0019
595 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 135 0.0019
596 POLLAKIURIA 79 0.0019
597 DIPLOPIA 49 0.0019
598 ABSCESS 30 0.0019
599 HEART RATE DECREASED 66 0.0019
600 OPTIC NEURITIS 17 0.0019
601 SCAR 32 0.0019
602 FISTULA 21 0.0019
603 SPINAL OPERATION 23 0.0019
604 HIDRADENITIS 17 0.0019
605 DIZZINESS POSTURAL 18 0.0019
606 CHOKING 36 0.0018
607 BACK INJURY 20 0.0018
608 CHOLECYSTECTOMY 21 0.0018
609 WRIST FRACTURE 22 0.0018
610 HEAD INJURY 58 0.0018
611 ORAL PAIN 41 0.0018
612 PRODUCT ADMINISTRATION ERROR 37 0.0018
613 SWELLING FACE 119 0.0018
614 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
615 PRODUCT DOSE OMISSION 119 0.0018
616 DEVICE BREAKAGE 74 0.0018
617 HYPERTENSION 385 0.0018
618 INTENTIONAL DRUG MISUSE 38 0.0018
619 PHOTOSENSITIVITY REACTION 30 0.0018
620 PARALYSIS 26 0.0018
621 COMPLICATION OF DEVICE INSERTION 36 0.0018
622 DRY EYE 90 0.0018
623 GASTROOESOPHAGEAL REFLUX DISEASE 144 0.0018
624 ASTHMA 202 0.0018
625 NASOPHARYNGITIS 329 0.0018
626 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
627 PRODUCT USE IN UNAPPROVED INDICATION 440 0.0018
628 EXPOSURE VIA SKIN CONTACT 46 0.0018
629 PSORIATIC ARTHROPATHY 72 0.0018
630 DRUG WITHDRAWAL SYNDROME 155 0.0018
631 PROCEDURAL PAIN 49 0.0018
632 MUSCULOSKELETAL STIFFNESS 154 0.0018
633 ERUCTATION 34 0.0018
634 SCIATICA 28 0.0018
635 ARRHYTHMIA 83 0.0018
636 LIVER INJURY 43 0.0018
637 VISUAL IMPAIRMENT 216 0.0017
638 BRONCHITIS 129 0.0017
639 SNEEZING 39 0.0017
640 DYSURIA 64 0.0017
641 HOT FLUSH 131 0.0017
642 GASTRIC ULCER 33 0.0017
643 PARAESTHESIA ORAL 25 0.0017
644 EXTRAPYRAMIDAL DISORDER 43 0.0017
645 LIMB INJURY 47 0.0017
646 SKIN SWELLING 15 0.0017
647 KNEE OPERATION 17 0.0017
648 TASTE DISORDER 35 0.0017
649 CYANOSIS 27 0.0017
650 FOOT DEFORMITY 19 0.0017
651 TOOTHACHE 31 0.0017
652 SPINAL DISORDER 16 0.0017
653 VOMITING 793 0.0017
654 OVERDOSE 363 0.0017
655 VAGINAL HAEMORRHAGE 73 0.0017
656 KIDNEY INFECTION 33 0.0017
657 VAGINAL DISCHARGE 17 0.0017
658 DYSARTHRIA 63 0.0017
659 BLOOD PRESSURE DECREASED 111 0.0017
660 MOTOR DYSFUNCTION 17 0.0017
661 LOSS OF LIBIDO 15 0.0017
662 EYE PAIN 94 0.0017
663 EMOTIONAL DISTRESS 201 0.0017
664 HYPERSENSITIVITY 308 0.0017
665 MALAISE 726 0.0017
666 URTICARIA 277 0.0017
667 FLUID RETENTION 84 0.0016
668 PELVIC PAIN 30 0.0016
669 VITREOUS FLOATERS 16 0.0016
670 GRAND MAL CONVULSION 15 0.0016
671 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
672 ABDOMINAL PAIN LOWER 41 0.0016
673 INCORRECT PRODUCT ADMINISTRATION DURATION 35 0.0016
674 ORTHOSTATIC HYPOTENSION 28 0.0016
675 PAIN IN EXTREMITY 473 0.0016
676 CONTUSION 154 0.0016
677 STATUS EPILEPTICUS 18 0.0016
678 LIP SWELLING 53 0.0016
679 BLOOD CHOLESTEROL INCREASED 74 0.0016
680 DYSPEPSIA 156 0.0016
681 SPUTUM DISCOLOURED 15 0.0016
682 PULMONARY EMBOLISM 150 0.0016
683 MUSCULOSKELETAL DISCOMFORT 27 0.0016
684 GALLBLADDER DISORDER 28 0.0016
685 NASAL CONGESTION 92 0.0016
686 INFLUENZA 174 0.0016
687 RASH 679 0.0016
688 EXTRA DOSE ADMINISTERED 63 0.0016
689 SINUS CONGESTION 21 0.0016
690 THROAT TIGHTNESS 42 0.0016
691 SKIN HAEMORRHAGE 23 0.0016
692 UVEITIS 21 0.0015
693 PAIN 949 0.0015
694 JOINT INJURY 33 0.0015
695 TACHYPNOEA 21 0.0015
696 IMMUNODEFICIENCY 23 0.0015
697 ABDOMINAL PAIN 357 0.0015
698 LOCALISED INFECTION 37 0.0015
699 ALOPECIA 299 0.0015
700 ORAL CANDIDIASIS 20 0.0015
701 TOOTH INFECTION 20 0.0015
702 CONJUNCTIVITIS 28 0.0015
703 ULCER 24 0.0015
704 MUSCLE RIGIDITY 18 0.0015
705 EPILEPSY 46 0.0015
706 HEPATIC STEATOSIS 28 0.0015
707 PHARYNGEAL OEDEMA 23 0.0015
708 SCAB 17 0.0015
709 ANAPHYLACTIC REACTION 82 0.0015
710 DRUG DEPENDENCE 238 0.0015
711 GLOSSODYNIA 33 0.0015
712 TOOTH ABSCESS 15 0.0015
713 ABORTION SPONTANEOUS 59 0.0015
714 SKIN DISORDER 49 0.0015
715 DYSPHAGIA 139 0.0015
716 FOETAL EXPOSURE DURING PREGNANCY 119 0.0015
717 ASPIRATION 16 0.0015
718 EYE DISORDER 48 0.0015
719 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
720 MULTIPLE SCLEROSIS 69 0.0014
721 ASTHENIA 542 0.0014
722 BURNING SENSATION 101 0.0014
723 CONVULSION 82 0.0014
724 CONSTIPATION 312 0.0014
725 MYALGIA 242 0.0014
726 BLOOD URINE PRESENT 27 0.0014
727 CANDIDA INFECTION 24 0.0014
728 ELECTROCARDIOGRAM QT PROLONGED 51 0.0014
729 JAUNDICE 38 0.0014
730 HEPATIC ENZYME INCREASED 96 0.0014
731 RHINORRHOEA 91 0.0014
732 BREAST PAIN 15 0.0014
733 UPPER LIMB FRACTURE 28 0.0014
734 DRUG EFFECT INCOMPLETE 51 0.0014
735 GLAUCOMA 27 0.0014
736 MYOCARDITIS 16 0.0014
737 BACK PAIN 323 0.0014
738 DISEASE RECURRENCE 66 0.0014
739 PYREXIA 479 0.0014
740 ABDOMINAL DISTENSION 144 0.0014
741 OESOPHAGITIS 15 0.0014
742 RASH MACULAR 48 0.0014
743 THYROID DISORDER 21 0.0014
744 LOWER LIMB FRACTURE 26 0.0014
745 CELLULITIS 68 0.0013
746 EYE SWELLING 50 0.0013
747 INFUSION RELATED REACTION 89 0.0013
748 BLOOD PRESSURE FLUCTUATION 32 0.0013
749 BLOOD POTASSIUM DECREASED 40 0.0013
750 MENORRHAGIA 26 0.0013
751 MUSCULAR WEAKNESS 150 0.0013
752 OSTEOPENIA 20 0.0013
753 SKIN LESION 36 0.0013
754 DEHYDRATION 173 0.0013
755 ABNORMAL WEIGHT GAIN 16 0.0013
756 FUNGAL INFECTION 43 0.0013
757 APHONIA 18 0.0013
758 FLUSHING 131 0.0013
759 VASCULITIS 15 0.0013
760 EYE IRRITATION 74 0.0013
761 SPINAL PAIN 15 0.0013
762 BALANCE DISORDER 110 0.0013
763 ARTHRALGIA 525 0.0013
764 DYSPHONIA 73 0.0012
765 CHILLS 146 0.0012
766 INFLUENZA LIKE ILLNESS 102 0.0012
767 HIATUS HERNIA 16 0.0012
768 METRORRHAGIA 21 0.0012
769 THROAT IRRITATION 55 0.0012
770 INJECTION SITE URTICARIA 30 0.0012
771 SKIN EXFOLIATION 103 0.0012
772 JOINT STIFFNESS 32 0.0012
773 NERVOUS SYSTEM DISORDER 38 0.0012
774 EPISTAXIS 91 0.0012
775 CYST 15 0.0012
776 ADVERSE REACTION 16 0.0012
777 ERYTHEMA 247 0.0012
778 COUGH 336 0.0012
779 GASTRIC DISORDER 41 0.0012
780 CHOLELITHIASIS 39 0.0012
781 GASTRITIS 31 0.0012
782 FALL 389 0.0012
783 PRODUCT PREPARATION ERROR 24 0.0012
784 SWELLING 109 0.0012
785 INJECTION SITE INDURATION 15 0.0012
786 ADRENAL INSUFFICIENCY 14 0.0012
787 ANGIOEDEMA 51 0.0012
788 CHROMATURIA 26 0.0012
789 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
790 INCORRECT PRODUCT STORAGE 15 0.0011
791 HERNIA 22 0.0011
792 PERIPHERAL SWELLING 175 0.0011
793 DYSPNOEA 641 0.0011
794 PRURITUS 435 0.0011
795 BLINDNESS 46 0.0011
796 TOOTH DISORDER 25 0.0011
797 STAPHYLOCOCCAL INFECTION 37 0.0011
798 GOUT 20 0.0011
799 PAIN OF SKIN 30 0.0011
800 DEVICE EXPULSION 72 0.0011
801 HAEMATOCRIT DECREASED 22 0.0011
802 BRAIN OEDEMA 14 0.0011
803 SKIN BURNING SENSATION 79 0.0011
804 MUSCULOSKELETAL CHEST PAIN 17 0.0011
805 TENDONITIS 17 0.0011
806 WHEEZING 65 0.0011
807 INJURY 77 0.0011
808 ILL-DEFINED DISORDER 66 0.0011
809 CEREBROVASCULAR ACCIDENT 184 0.0011
810 DEVICE USE ISSUE 19 0.0011
811 UNDERDOSE 78 0.0011
812 PRODUCT COMPLAINT 27 0.0011
813 OCULAR HYPERAEMIA 50 0.0011
814 BLISTER 59 0.0010
815 KNEE ARTHROPLASTY 22 0.0010
816 DRY SKIN 139 0.0010
817 STEVENS-JOHNSON SYNDROME 23 0.0010
818 PRODUCT STORAGE ERROR 90 0.0010
819 PRODUCTIVE COUGH 49 0.0010
820 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
821 EXPIRED PRODUCT ADMINISTERED 34 0.0010
822 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
823 CARDIOMYOPATHY 15 0.0010
824 EYE PRURITUS 34 0.0010
825 UNRESPONSIVE TO STIMULI 26 0.0010
826 INJECTION SITE SWELLING 77 0.0010
827 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
828 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
829 ARTHROPATHY 55 0.0010
830 PSORIASIS 129 0.0010
831 GAIT INABILITY 33 0.0010
832 RASH PAPULAR 22 0.0010
833 INJECTION SITE RASH 30 0.0010
834 HOSPITALISATION 150 0.0010
835 COLITIS 37 0.0010
836 INFECTION 141 0.0010
837 RIB FRACTURE 20 0.0010
838 GENERAL PHYSICAL HEALTH DETERIORATION 112 0.0010
839 AGEUSIA 24 0.0010
840 DYSSTASIA 28 0.0010
841 INFLAMMATION 49 0.0009
842 TOXICITY TO VARIOUS AGENTS 160 0.0009
843 ANGINA PECTORIS 27 0.0009
844 COMPLETED SUICIDE 78 0.0009
845 DIARRHOEA 604 0.0009
846 MUSCULOSKELETAL PAIN 49 0.0009
847 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
848 LACRIMATION INCREASED 28 0.0009
849 STOMATITIS 56 0.0009
850 INCORRECT DOSE ADMINISTERED BY DEVICE 24 0.0009
851 URINARY TRACT INFECTION 156 0.0009
852 INJECTION SITE PAIN 280 0.0009
853 THERAPY NON-RESPONDER 41 0.0009
854 JOINT SWELLING 110 0.0009
855 HAEMATEMESIS 23 0.0009
856 HERPES ZOSTER 52 0.0009
857 MOBILITY DECREASED 65 0.0009
858 BLOOD SODIUM DECREASED 17 0.0009
859 INJECTION SITE REACTION 62 0.0009
860 MENTAL STATUS CHANGES 25 0.0009
861 RASH ERYTHEMATOUS 43 0.0009
862 OSTEOARTHRITIS 38 0.0009
863 GAIT DISTURBANCE 171 0.0009
864 RASH GENERALISED 23 0.0009
865 RASH PRURITIC 48 0.0009
866 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
867 INJECTION SITE BRUISING 69 0.0009
868 FLATULENCE 49 0.0009
869 RHABDOMYOLYSIS 36 0.0009
870 NEEDLE ISSUE 25 0.0009
871 WOUND 24 0.0009
872 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
873 CYSTITIS 27 0.0008
874 DRUG ADMINISTRATION ERROR 26 0.0008
875 RHEUMATOID ARTHRITIS 96 0.0008
876 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
877 MULTIPLE SCLEROSIS RELAPSE 57 0.0008
878 CARDIOVASCULAR DISORDER 21 0.0008
879 DEVICE ISSUE 74 0.0008
880 ENCEPHALOPATHY 20 0.0008
881 DIABETES MELLITUS 62 0.0008
882 SKIN ULCER 21 0.0008
883 BLOOD GLUCOSE ABNORMAL 15 0.0008
884 INJECTION SITE MASS 30 0.0008
885 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
886 DRUG DOSE OMISSION BY DEVICE 63 0.0008
887 BACTERIAL INFECTION 15 0.0008
888 DEAFNESS 21 0.0008
889 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27 0.0008
890 RESPIRATORY ARREST 22 0.0008
891 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
892 INTESTINAL OBSTRUCTION 30 0.0008
893 HAEMORRHAGE 83 0.0008
894 MUSCULOSKELETAL DISORDER 15 0.0008
895 SKIN IRRITATION 36 0.0008
896 DEVICE DISLOCATION 34 0.0008
897 ABASIA 19 0.0008
898 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
899 DIVERTICULITIS 21 0.0008
900 PANCREATITIS ACUTE 17 0.0008
901 BONE PAIN 44 0.0008
902 HYPOTENSION 150 0.0007
903 LIVER FUNCTION TEST INCREASED 16 0.0007
904 INJECTION SITE PRURITUS 49 0.0007
905 IMPAIRED HEALING 24 0.0007
906 BLOOD GLUCOSE DECREASED 35 0.0007
907 ACCIDENTAL EXPOSURE TO PRODUCT 75 0.0007
908 NEUROPATHY PERIPHERAL 69 0.0007
909 TOOTH LOSS 15 0.0007
910 C-REACTIVE PROTEIN INCREASED 26 0.0007
911 HEPATITIS 18 0.0007
912 PANCREATITIS 37 0.0007
913 HAEMATOMA 18 0.0007
914 PRURITUS GENERALISED 15 0.0007
915 FAECES DISCOLOURED 15 0.0007
916 DEVICE LEAKAGE 30 0.0007
917 APPLICATION SITE PAIN 15 0.0007
918 CARDIAC ARREST 56 0.0007
919 CATARACT 40 0.0007
920 PNEUMONIA 217 0.0007
921 BLOOD BILIRUBIN INCREASED 18 0.0007
922 HYPOKALAEMIA 30 0.0006
923 OEDEMA PERIPHERAL 78 0.0006
924 DRUG-INDUCED LIVER INJURY 20 0.0006
925 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
926 OEDEMA 34 0.0006
927 TYPE 2 DIABETES MELLITUS 21 0.0006
928 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
929 INJECTION SITE ERYTHEMA 77 0.0006
930 ANAPHYLACTIC SHOCK 16 0.0006
931 THROMBOSIS 49 0.0006
932 VISUAL ACUITY REDUCED 20 0.0006
933 BRADYCARDIA 31 0.0006
934 RENAL DISORDER 27 0.0006
935 HYPOGLYCAEMIA 28 0.0006
936 CARDIAC DISORDER 54 0.0006
937 DELIRIUM 20 0.0006
938 INJECTION SITE HAEMORRHAGE 46 0.0006
939 APPLICATION SITE ERYTHEMA 15 0.0006
940 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
941 HYPOXIA 20 0.0006
942 CHRONIC KIDNEY DISEASE 43 0.0006
943 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
944 LIVER DISORDER 25 0.0006
945 PRODUCT ADHESION ISSUE 20 0.0006
946 HYPOACUSIS 24 0.0006
947 LIVER FUNCTION TEST ABNORMAL 16 0.0005
948 LABORATORY TEST ABNORMAL 16 0.0005
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 25 0.0005
950 OSTEOPOROSIS 22 0.0005
951 DYSPNOEA EXERTIONAL 20 0.0005
952 RESPIRATORY DISORDER 15 0.0005
953 DEPENDENCE 27 0.0005
954 LEUKOPENIA 24 0.0005
955 LACTIC ACIDOSIS 15 0.0005
956 PULMONARY OEDEMA 20 0.0004
957 DEVICE MALFUNCTION 31 0.0004
958 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
959 CEREBRAL HAEMORRHAGE 15 0.0004
960 OXYGEN SATURATION DECREASED 22 0.0004
961 BLOOD CREATININE INCREASED 25 0.0004
962 ATRIAL FIBRILLATION 36 0.0004
963 LUNG DISORDER 18 0.0004
964 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
965 FEBRILE NEUTROPENIA 24 0.0004
966 ANAEMIA 69 0.0004
967 RENAL FAILURE 48 0.0004
968 RENAL IMPAIRMENT 29 0.0003
969 COMA 16 0.0003
970 MYOCARDIAL INFARCTION 58 0.0003
971 SEPSIS 37 0.0003
972 NEOPLASM MALIGNANT 22 0.0003
973 BREAST CANCER 30 0.0003
974 ACUTE KIDNEY INJURY 48 0.0003
975 BLOOD GLUCOSE INCREASED 59 0.0003
976 HYPONATRAEMIA 16 0.0003
977 CARDIAC FAILURE 22 0.0003
978 HAEMOGLOBIN DECREASED 28 0.0003
979 RESPIRATORY FAILURE 19 0.0003
980 DEVICE DIFFICULT TO USE 16 0.0002
981 NEUTROPENIA 30 0.0002
982 PLATELET COUNT DECREASED 20 0.0002
983 DISEASE PROGRESSION 22 0.0002
984 CARDIAC FAILURE CONGESTIVE 14 0.0002
985 THROMBOCYTOPENIA 16 0.0001
986 DEATH 103 0.0001